Many pancreatic cancer patients with BRCA and PALB2 mutations saw their tumors stop growing or shrink substantially after being switched from chemotherapy to the PARP inhibitor rucaparib, according to results from a clinical trial led by Basser Center researchers.

Susan Domchek, MD, Basser Center Executive Director, was quoted in a Wall Street Journal article that profiled a woman’s experience with genetic testing and a surprising family tree that led her to make decisions about her cancer care.

Philly Voice highlights our Black & BRCA initiative, which launched last fall to help raise  awareness about genetic testing in the Black community. 

In an op-ed, Basser Director of Genetics Katherine L. Nathanson, MD, joined other Penn physicians in offering strategies to “nudge” oncologists to overcome race as a heuristic in decision-making.

Basser researcher Kim Reiss Binder, MD, was featured in a series of videos on the latest in pancreatic cancer research and therapies, discussing immunotherapies, early detection, and metastatic disease.

Basser Executive Director Susan Domchek, MD, was quoted in a story on the ambiguity of certain genetic tests and how “variants of unknown significance” (VUS) can guide cancer treatments, despite a lack of evidence to support those decisions.

This helpful list of cancer survivors to follow on Instagram includes Alejandra Campoverdi, our partner on LATINX & BRCA.

Everviolet talked to Basser Young Leadership Council co-chair Erika Stallings about her experience with BRCA and hereditary cancer.

Basser clinician Kim Reiss-Binder, MD, was quoted in an article on symptoms that often occur in the later stages of pancreatic cancer.

A team of researchers led by Katherine L. Nathanson, MD, Basser Director of Genetics, Deputy Director of the Abramson Cancer Center, and the Pearl Basser Professor for BRCA-Related Research, was recently awarded $5.4 million over five years from the National Institutes of Health to continue the long-standing genomics work of the TEsticular CAncer Consortium (TECAC).